Sandy Cove Advisors, LLC Bristol Myers Squibb CO Transaction History

Sandy Cove Advisors, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 17, 2024	BUY	$47.98 - $54.4 $27,204 - $30,844	567 Added 14.01%	4,615 $250,000
Q4 2023 Jan 17, 2024	BUY	$48.48 - $57.85 $8,387 - $10,008	173 Added 4.46%	4,048 $207,000
Q2 2023 Aug 14, 2023	SELL	$63.71 - $70.74 $6,816 - $7,569	-107 Reduced 2.69%	3,875 $247,000
Q1 2023 May 12, 2023	BUY	$65.71 - $74.53 $7,030 - $7,974	107 Added 2.76%	3,982 $275,000
Q4 2021 Feb 04, 2022	BUY	$53.63 - $62.52 $207,816 - $242,265	3,875 New	3,875 $242,000

2,533

1.47B

31.6M

35M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $124B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Sandy Cove Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Sandy Cove Advisors, LLC with notifications on news.